{"id":32667,"date":"2024-08-09T18:04:08","date_gmt":"2024-08-09T16:04:08","guid":{"rendered":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/"},"modified":"2024-08-09T18:04:08","modified_gmt":"2024-08-09T16:04:08","slug":"bpco-non-controllata-via-libera-a-dupilumab","status":"publish","type":"post","link":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/","title":{"rendered":"BPCO non controllata, via libera a Dupilumab"},"content":{"rendered":"<p>    <video-js id=\"videojs6812e3e302d48\" class=\"vjs-big-play-centered\" controls preload=\"auto\" playsinline data-setup='{\"fluid\": true}'>\r\n        <source src=\"https:\/\/video.italpress.com\/play\/mp4\/video\/EQR4\" type=\"video\/mp4\" \/>\r\n    <\/video-js>\r\n           <br \/>\n<\/p>\n<div> ROMA (ITALPRESS) &#8211; L&#8217;Agenzia Europea dei Medicinali ha approvato dupilumab, anticorpo monoclonale completamente umano, come trattamento aggiuntivo di mantenimento per gli adulti affetti da broncopneumopatia cronica ostruttiva non controllata, caratterizzata da un aumento degli eosinofili nel sangue. L&#8217;approvazione dell\u2019EMA si basa sui risultati di due storici studi di fase 3 che sono stati pubblicati separatamente sul New England Journal of Medicine. <br \/>\nsat\/gtr<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROMA (ITALPRESS) &#8211; L&#8217;Agenzia Europea dei Medicinali ha approvato dupilumab, anticorpo monoclonale completamente umano, come trattamento aggiuntivo di mantenimento per gli adulti affetti da broncopneumopatia cronica ostruttiva non controllata, caratterizzata da un aumento degli eosinofili nel sangue. L&#8217;approvazione dell\u2019EMA si basa sui risultati di due storici studi di fase 3 che sono stati pubblicati separatamente [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":32668,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[1171],"tags":[],"class_list":["post-32667","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-video","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BPCO non controllata, via libera a Dupilumab - Live Magazine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPCO non controllata, via libera a Dupilumab - Live Magazine\" \/>\n<meta property=\"og:description\" content=\"ROMA (ITALPRESS) &#8211; L&#8217;Agenzia Europea dei Medicinali ha approvato dupilumab, anticorpo monoclonale completamente umano, come trattamento aggiuntivo di mantenimento per gli adulti affetti da broncopneumopatia cronica ostruttiva non controllata, caratterizzata da un aumento degli eosinofili nel sangue. L&#8217;approvazione dell\u2019EMA si basa sui risultati di due storici studi di fase 3 che sono stati pubblicati separatamente [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Magazine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LiveMag\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-09T16:04:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/ograph.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"italpress\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@LiveNotizie\" \/>\n<meta name=\"twitter:site\" content=\"@LiveNotizie\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"italpress\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\"},\"author\":{\"name\":\"italpress\",\"@id\":\"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c\"},\"headline\":\"BPCO non controllata, via libera a Dupilumab\",\"datePublished\":\"2024-08-09T16:04:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\"},\"wordCount\":81,\"publisher\":{\"@id\":\"https:\/\/www.livemag.it\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg\",\"articleSection\":[\"Video\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\",\"url\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\",\"name\":\"BPCO non controllata, via libera a Dupilumab - Live Magazine\",\"isPartOf\":{\"@id\":\"https:\/\/www.livemag.it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg\",\"datePublished\":\"2024-08-09T16:04:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage\",\"url\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg\",\"contentUrl\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.livemag.it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPCO non controllata, via libera a Dupilumab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.livemag.it\/#website\",\"url\":\"https:\/\/www.livemag.it\/\",\"name\":\"Live Magazine\",\"description\":\"Varie ed eventi\",\"publisher\":{\"@id\":\"https:\/\/www.livemag.it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.livemag.it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.livemag.it\/#organization\",\"name\":\"LiveMag\",\"alternateName\":\"LiveMag News ed eventi\",\"url\":\"https:\/\/www.livemag.it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg\",\"contentUrl\":\"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg\",\"width\":696,\"height\":696,\"caption\":\"LiveMag\"},\"image\":{\"@id\":\"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LiveMag\/\",\"https:\/\/x.com\/LiveNotizie\",\"https:\/\/www.instagram.com\/livemag\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c\",\"name\":\"italpress\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.livemag.it\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fe9feb45ad01fb32d40a34c13f2841a5?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fe9feb45ad01fb32d40a34c13f2841a5?s=96&r=g\",\"caption\":\"italpress\"},\"description\":\"Italpress \u00e8 un'agenzia di stampa italiana a carattere nazionale.\",\"url\":\"https:\/\/www.livemag.it\/index.php\/author\/italpress\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BPCO non controllata, via libera a Dupilumab - Live Magazine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/","og_locale":"it_IT","og_type":"article","og_title":"BPCO non controllata, via libera a Dupilumab - Live Magazine","og_description":"ROMA (ITALPRESS) &#8211; L&#8217;Agenzia Europea dei Medicinali ha approvato dupilumab, anticorpo monoclonale completamente umano, come trattamento aggiuntivo di mantenimento per gli adulti affetti da broncopneumopatia cronica ostruttiva non controllata, caratterizzata da un aumento degli eosinofili nel sangue. L&#8217;approvazione dell\u2019EMA si basa sui risultati di due storici studi di fase 3 che sono stati pubblicati separatamente [&hellip;]","og_url":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/","og_site_name":"Live Magazine","article_publisher":"https:\/\/www.facebook.com\/LiveMag\/","article_published_time":"2024-08-09T16:04:08+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/ograph.jpg","type":"image\/jpeg"}],"author":"italpress","twitter_card":"summary_large_image","twitter_creator":"@LiveNotizie","twitter_site":"@LiveNotizie","twitter_misc":{"Scritto da":"italpress"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#article","isPartOf":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/"},"author":{"name":"italpress","@id":"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c"},"headline":"BPCO non controllata, via libera a Dupilumab","datePublished":"2024-08-09T16:04:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/"},"wordCount":81,"publisher":{"@id":"https:\/\/www.livemag.it\/#organization"},"image":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg","articleSection":["Video"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/","url":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/","name":"BPCO non controllata, via libera a Dupilumab - Live Magazine","isPartOf":{"@id":"https:\/\/www.livemag.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage"},"image":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg","datePublished":"2024-08-09T16:04:08+00:00","breadcrumb":{"@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#primaryimage","url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg","contentUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.livemag.it\/index.php\/2024\/08\/09\/bpco-non-controllata-via-libera-a-dupilumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.livemag.it\/"},{"@type":"ListItem","position":2,"name":"BPCO non controllata, via libera a Dupilumab"}]},{"@type":"WebSite","@id":"https:\/\/www.livemag.it\/#website","url":"https:\/\/www.livemag.it\/","name":"Live Magazine","description":"Varie ed eventi","publisher":{"@id":"https:\/\/www.livemag.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.livemag.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.livemag.it\/#organization","name":"LiveMag","alternateName":"LiveMag News ed eventi","url":"https:\/\/www.livemag.it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg","contentUrl":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/02\/immagine-sito.jpg","width":696,"height":696,"caption":"LiveMag"},"image":{"@id":"https:\/\/www.livemag.it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LiveMag\/","https:\/\/x.com\/LiveNotizie","https:\/\/www.instagram.com\/livemag\/"]},{"@type":"Person","@id":"https:\/\/www.livemag.it\/#\/schema\/person\/b62c5f44451fdcdaeb0afe6c2424e73c","name":"italpress","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.livemag.it\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fe9feb45ad01fb32d40a34c13f2841a5?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fe9feb45ad01fb32d40a34c13f2841a5?s=96&r=g","caption":"italpress"},"description":"Italpress \u00e8 un'agenzia di stampa italiana a carattere nazionale.","url":"https:\/\/www.livemag.it\/index.php\/author\/italpress\/"}]}},"jetpack_featured_media_url":"https:\/\/www.livemag.it\/wp-content\/uploads\/2024\/08\/EQR4.jpg","_links":{"self":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts\/32667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/comments?post=32667"}],"version-history":[{"count":0,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/posts\/32667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/media\/32668"}],"wp:attachment":[{"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/media?parent=32667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/categories?post=32667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.livemag.it\/index.php\/wp-json\/wp\/v2\/tags?post=32667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}